Webinar: Ensuring compliance with animal-free raw materials in CGT
Webinar details Thursday, November 20, 2025 10am EST (NA) / 3pm GMT (UK) / 4pm CET · 60 min The production of cell and gene therapies requires strict adherence to regulatory standards that ensure patient safety and product consistency. However, sourcing high-performing, animal-free raw materials that meet these standards remains a major challenge for many […]
Enhancing efficiency and safety in upstream biomanufacturing
Accelerate the scale-up to clinical phase: Optimizing stem cell culture performance and viral vector titers
Enhancing process efficiency with high-quality animal-free ingredients
Case study – Boost the production of monoclonal antibodies in CHO cells
Case study- Increase the viral vector production in HEK293 cells
Recombinant Insulin is the essential cell culture ingredient to boost cell proliferation and productivity
Effect of Insulin on influenza virus production in HEK293 Cells
Mammalian cells are considered an alternative to eggs for the production of influenza vaccines. HEK293SF-3F6 is a suspension GMP cell line that grows in serum-free media, and influenza production has been achieved in flasks and large bioreactors. To boost influenza production, insulin was added to the cultures. This growth factor was chosen because it has […]
